Carboplatin: the clinical evaluation strategy.

Suppr

超能文献

作者信息

Rozencweig M, Canetta R, Carter S K

出版信息

Cancer Treat Rev. 1985 Sep;12 Suppl A:137-44. doi: 10.1016/0305-7372(85)90028-3.

DOI:10.1016/0305-7372(85)90028-3

PMID:3910217

Abstract

摘要

相似文献

Carboplatin: the clinical evaluation strategy.

Cancer Treat Rev. 1985 Sep;12 Suppl A:137-44. doi: 10.1016/0305-7372(85)90028-3.

Carboplatin: the clinical spectrum to date.

Cancer Treat Rev. 1985 Sep;12 Suppl A:125-36. doi: 10.1016/0305-7372(85)90027-1.

Carboplatin in the first-line chemotherapy of ovarian cancer.

Semin Oncol. 1990 Feb;17(1 Suppl 2):54-60.

Ovarian trials at the Royal Marsden.

Cancer Treat Rev. 1985 Sep;12 Suppl A:67-71. doi: 10.1016/0305-7372(85)90020-9.

Carboplatin in the treatment of ovarian cancer.

Semin Oncol. 1989 Apr;16(2 Suppl 5):19-26.

Carboplatin and ifosfamide in ovarian cancer phase II and III trials. London Gynaecological Oncology Group.

Cancer Chemother Pharmacol. 1990;26 Suppl:S48-50. doi: 10.1007/BF00685419.

Carboplatin: current status and future prospects.

Cancer Treat Rev. 1988 Jun;15 Suppl B:17-32. doi: 10.1016/0305-7372(88)90031-x.

Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer.

Gynecol Oncol. 2002 Apr;85(1):71-80. doi: 10.1006/gyno.2001.6552.

Whither carboplatin.

J Clin Oncol. 1987 Jun;5(6):984-6. doi: 10.1200/JCO.1987.5.6.984.

Carboplatin.

Med Lett Drugs Ther. 1989 Sep 8;31(800):83-4.

引用本文的文献

Carboplatin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer.

Drugs. 1989 Feb;37(2):162-90. doi: 10.2165/00003495-198937020-00005.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Carboplatin: the clinical evaluation strategy.

Cancer Treat Rev. 1985 Sep;12 Suppl A:137-44. doi: 10.1016/0305-7372(85)90028-3.

Carboplatin: the clinical spectrum to date.

Cancer Treat Rev. 1985 Sep;12 Suppl A:125-36. doi: 10.1016/0305-7372(85)90027-1.

Carboplatin in the first-line chemotherapy of ovarian cancer.

Semin Oncol. 1990 Feb;17(1 Suppl 2):54-60.

Ovarian trials at the Royal Marsden.

Cancer Treat Rev. 1985 Sep;12 Suppl A:67-71. doi: 10.1016/0305-7372(85)90020-9.

Carboplatin in the treatment of ovarian cancer.

Semin Oncol. 1989 Apr;16(2 Suppl 5):19-26.

Carboplatin and ifosfamide in ovarian cancer phase II and III trials. London Gynaecological Oncology Group.

Cancer Chemother Pharmacol. 1990;26 Suppl:S48-50. doi: 10.1007/BF00685419.

Carboplatin: current status and future prospects.

Cancer Treat Rev. 1988 Jun;15 Suppl B:17-32. doi: 10.1016/0305-7372(88)90031-x.

Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer.

Gynecol Oncol. 2002 Apr;85(1):71-80. doi: 10.1006/gyno.2001.6552.

Whither carboplatin.

J Clin Oncol. 1987 Jun;5(6):984-6. doi: 10.1200/JCO.1987.5.6.984.

Carboplatin.

Med Lett Drugs Ther. 1989 Sep 8;31(800):83-4.

引用本文的文献

Carboplatin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer.

Drugs. 1989 Feb;37(2):162-90. doi: 10.2165/00003495-198937020-00005.